Interferon alfa-2b therapy for extensive vision-threatening facial hemangioma

P. Rampini, C. Occella, D. Bleidl, E. Rampini

Research output: Contribution to journalArticlepeer-review


On the basis of recent reports on the effects of interferon on hemangiomas we used interferon alfa-2b therapy in a three month old child with extensive vision threatening facial hemangioma refractory to systemic corticosteroids. After nine months of therapy with interferon the hemangioma regressed almost completely. No regrowth has been observed after a follow-up of 13 months.

Original languageEnglish
Pages (from-to)502-504
Number of pages3
JournalNouvelles Dermatologiques
Issue number8
Publication statusPublished - 1995


  • hemangioma
  • interferon alfa-2b

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Interferon alfa-2b therapy for extensive vision-threatening facial hemangioma'. Together they form a unique fingerprint.

Cite this